Trials / Sponsors / Melt Pharmaceuticals
Melt Pharmaceuticals
Industry · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Ex Cataract | Phase 3 | 2024-05-01 |
| Completed | A Study of MELT-300 (Midazolam and Ketamine Sublingual Tablets) for Sedation and Intraoperative Ocular Analges Cataract | Phase 2 | 2021-07-20 |
| Completed | Relative Bioavailability Study of MELT-100, IV Midazolam, and IV Ketamine Procedural Sedation | Phase 1 | 2020-12-01 |
| Completed | Phase 1 Bioavailability Study of MELT-100 (Midazolam and Ketamine Sublingual) and IV Midazolam or Ketamine Healthy Volunteers | Phase 1 | 2020-07-20 |